BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
3097 results:

  • 1. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
    Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
    Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action.
    Sehdev S; Gotfrit J; Elias M; Stein BD
    Curr Oncol; 2024 Mar; 31(3):1460-1469. PubMed ID: 38534943
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prophylactic defunctioning stomas improve clinical outcomes of anastomotic leak following rectal cancer resections: An analysis of the US Rectal cancer Consortium.
    Hrebinko K; Anto VP; Reitz KM; Gamboa AC; Regenbogen SE; Hawkins AT; Hopkins MB; Ejaz A; Bauer PS; Wise PE; Balch GC; Holder-Murray J
    Int J Colorectal Dis; 2024 Mar; 39(1):39. PubMed ID: 38498217
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Cell-free DNA Blood-Based Test for colorectal cancer Screening.
    Chung DC; Gray DM; Singh H; Issaka RB; Raymond VM; Eagle C; Hu S; Chudova DI; Talasaz A; Greenson JK; Sinicrope FA; Gupta S; Grady WM
    N Engl J Med; 2024 Mar; 390(11):973-983. PubMed ID: 38477985
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical efficacy of acupuncture in treating postoperative gastrointestinal dysfunction of colorectal cancer, a systematic review and meta analysis.
    Zhou T; Wang S; Fan BJ; Zhang LX; Hu SH; Hou W
    Zhen Ci Yan Jiu; 2024 Feb; 49(2):208-219. PubMed ID: 38413043
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.
    Saeed A; Park R; Pathak H; Al-Bzour AN; Dai J; Phadnis M; Al-Rajabi R; Kasi A; Baranda J; Sun W; Williamson S; Chiu YC; Osmanbeyoglu HU; Madan R; Abushukair H; Mulvaney K; Godwin AK; Saeed A
    Nat Commun; 2024 Feb; 15(1):1533. PubMed ID: 38378868
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prevalence of Colonic Polyps Detected by Colonoscopy in Symptomatic Patients and Comparison Between Different Age Groups. What Age Should be Considered for Investigation?
    Ejtehadi F; Taghavi AR; Ejtehadi F; Shahramian I; Niknam R; Moini M; Tahani M
    Pol Przegl Chir; 2023 Jul; 96(1):15-21. PubMed ID: 38353090
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sidedness is not a prognostic factor in an unselected cohort of patients with colon cancer but prognosis for caecal carcinoma is worse - A multivariate analysis of a large single institution database.
    Stelzner S; Mehdorn M; Puffer E; Bleyl D; Kittner T; Rhode P; Gockel I; Mees ST
    Int J Colorectal Dis; 2024 Feb; 39(1):27. PubMed ID: 38349566
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
    Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
    Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. INTRA-ARTERIAL CHEMOTHERAPY AS A CLINICAL OPTION FOR metASTATIC colorectal cancer: CONVERSION OF INOPERABLE LIVER metASTASES TO OPERABLE ILLUSTRATED WITH A CLINICAL CASE.
    Cherchenko K; Lukashenko A; Ostapenko Y; Patsko V; Vinohradova M; Valikhnovska K; Pamanska S
    Exp Oncol; 2024 Feb; 45(4):515-522. PubMed ID: 38328838
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index.
    Sachdev R; Shearn-Nance G; Vu L; Bensken WP; Douglas SL; Koroukian SM; Rose J
    J Geriatr Oncol; 2024 Mar; 15(2):101706. PubMed ID: 38320468
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
    Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
    Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Characteristics and clinical analysis of MLH1 c.463dupC gene mutation in a Lynch syndrome family].
    Zhou DY; Liu C; Huang J; Xu N; Ji X; Yang KX; Peng JB; Pan H; Xu WJ; Zhu Z
    Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):547-551. PubMed ID: 38317368
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Preoperative CA 19-9 Predicts Disease Progression in colorectal Peritoneal metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
    Fackche NT; Schmocker RK; Nudotor R; Kubi B; Cloyd JM; Grotz TE; Fournier KF; Dineen SP; Veerapong J; Baumgartner JM; Clarke CN; Patel SH; Wilson GC; Lambert LA; Pokrzywa C; Abbott DE; Lee B; Staley CA; Zaidi MY; Johnston FM; Greer JB
    Ann Surg Oncol; 2024 May; 31(5):3314-3324. PubMed ID: 38310181
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Two Cases Suspected of Lynch Syndrome Caused by Juvenile Rectal cancer].
    Aomatsu N; Tsujio G; Aomatsu K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1900-1902. PubMed ID: 38303246
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The applications of augmented reality in image-guided tumor ablations: A scoping review.
    Al-Naser Y; Halka F; Alshadeedi F; Albahhar M; Athreya S
    J Med Imaging Radiat Sci; 2024 Mar; 55(1):125-133. PubMed ID: 38290953
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Barriers and facilitators for people with severe mental illness accessing cancer screening: A systematic review.
    Tuschick E; Barker J; Giles EL; Jones S; Hogg J; Kanmodi KK; Sill J; Sykes K
    Psychooncology; 2024 Jan; 33(1):e6274. PubMed ID: 38282230
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. United States-Based colorectal cancer Surgical Trials Lack Representation and Adequate Reporting of Racially and Ethnically Diverse Participants: Systematic Review and Regression Analysis.
    Ore AS; Areán-Sanz R; Liu BS; Arndt KR; Hernandez Alvarez A; Ponce CJ; Bain PA; Messaris E
    Dis Colon Rectum; 2024 May; 67(5):624-633. PubMed ID: 38276952
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Wound infection prevention strategies in colorectal endoscopic mucosal resection: A meta-analysis of prophylactic measures.
    Qi H; Wang Z; Shen F; Yu W; Duan S; Li X; Huang X
    Int Wound J; 2024 Jan; 21(1):e14544. PubMed ID: 38272812
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of interhospital competition on mortality of patients operated on for colorectal cancer faced to hospital volume and rurality: A cross-sectional study.
    Goro S; Challine A; Lefèvre JH; Epaud S; Lazzati A
    PLoS One; 2024; 19(1):e0291672. PubMed ID: 38271446
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 155.